Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CARM1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of CARM1 mRNA | affects expression | 21346803
|
D000242 |
Cyclic AMP |
CARM1 protein promotes the reaction [Cyclic AMP results in increased activity of ESR1 protein] | increases activity|increases reaction | 20360387
|
D000242 |
Cyclic AMP |
CARM1 protein promotes the reaction [Cyclic AMP results in increased expression of TFF1 mRNA] | increases expression|increases reaction | 20360387
|
D000242 |
Cyclic AMP |
Cyclic AMP promotes the reaction [CARM1 protein binds to ESR1 protein] | affects binding|increases reaction | 20360387
|
D000242 |
Cyclic AMP |
Cyclic AMP promotes the reaction [CARM1 protein binds to TFF1 promoter] | affects binding|increases reaction | 20360387
|
D000242 |
Cyclic AMP |
Cyclic AMP results in increased phosphorylation of CARM1 protein | increases phosphorylation | 20360387
|
D000242 |
Cyclic AMP |
[Cyclic AMP results in increased phosphorylation of CARM1 protein] promotes the reaction [CARM1 protein binds to ESR1 protein] | affects binding|increases phosphorylation|increases reaction | 20360387
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [CARM1 protein binds to ESR1 promoter] | affects binding|increases reaction | 19351845
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [TP53 protein binds to CARM1 protein] | affects binding|increases reaction | 19351845
|
D004958 |
Estradiol |
Estradiol promotes the reaction [CARM1 protein binds to TFF1 promoter] | affects binding|increases reaction | 20360387
|
D013629 |
Tamoxifen |
[CARM1 protein binds to ESR1 protein] which affects the susceptibility to Tamoxifen | affects binding|affects response to substance | 20360387
|
D013629 |
Tamoxifen |
CARM1 protein promotes the reaction [Tamoxifen results in increased activity of ESR1 protein] | increases activity|increases reaction | 20360387
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.41 | 7525203 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.71 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.71 | 11473722 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.93 | 21441931 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.22 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.11 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.93 | 19526202 15692762 18695136 16935488 15136595 15567936 16264153 16322301 18628466 16595493 18234424 15634643 16115903 15939500 11325840 17426702 16096432 16826403 17369602 15994142 18382427 15993339 17983394 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.93 | 12948864 16675129 14630087 19861407 18497071 17261762 17289903 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19410462 19189212 21138602 15565566 19059307 20135344 19288272 20859285 16873071 19115204 17242785 20390343 19244106 20544844 17049068 19189210 19487384 17893378 17440819 18629630 19103187 19011961 16273361 11161223 18997820 17261762 18855134 15668708 18351453 19155303 16202921 19084267 18821012 21152245 18984771 19200415 18425577 19221464 19289846 18815881 16818667 19066611 20065188 20005174 19142967 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.93 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.33 | 16051944 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.92 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.92 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.92 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.92 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.28 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.72 | 15792986 17974986 16952015 15811867 18627295 17382496 17351982 17007740 16269455 17924179 16278810 16612575 17928571 17519947 15505089 16455267 17329180 16364871 16731534 15476868 16651473 16242529 16109756 17308081 17131338 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.03 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.79 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.98 | 18566989 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.45 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.43 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.81 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.81 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.83 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
6.83 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.83 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.90 | 18602426 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.92 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
13.61 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
13.61 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
13.61 | 20544844 16202921 19155303 17893378 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.68 | 18037988 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
3.49 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
13.03 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
13.03 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.54 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.73 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.69 | 18006777 17888722 16879835 16707910 16495754 18674790 16244372 16330681 17875725 12587719 14766674 16144979 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.52 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.23 | 15692506 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.55 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.69 | 15147373 17606976 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.27 | 17088409 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.49 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.16 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.75 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.75 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.48 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
14.01 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
14.01 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
14.01 | 18625569 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.68 | 16085563 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.71 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.71 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.71 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
2.31 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.65 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.65 | 18625569 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.68 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.06 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.98 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.12 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.12 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.12 | 16827153 14580682 19196723 11731420 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
14.45 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
14.45 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.55 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.55 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.16 | 17638057 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
5.54 | 11304026 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.83 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.25 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.05 | 15857846 19429709 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.52 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.32 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.22 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.22 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.19 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.19 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.29 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.03 | 16427766 11399458 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.40 | 15555623 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.16 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
10.16 | 14694615 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.37 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.29 | 19401270 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.68 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.68 | 17638057 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.53 | 16868541 15897917 16729912 16888761 15749863 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.53 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.53 | 15067354 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.64 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.29 | 15675481 17203757 17710206 16767912 15625365 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.62 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.25 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.73 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.08 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.98 | 15625365 16767912 17203757 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.81 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.61 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.21 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.96 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.96 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.96 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.78 | 10091137 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.64 | 17638931 16364871 17334414 17678736 |